Chronic wounds in diabetes can take months to heal. In a diabetes mouse model, this new gel led to a 90% wound closure rate in just 12 days.

Treating pre-diabetic mice resulted in a lower rate of diabetes development from 58% to 18%. This research in mice is a key first step in the development of treatments for human patients.

Scientists have created a novel, long-lasting "smart" insulin that self-activates when blood sugar soars. Tests on mouse models for type 1 diabetes show that one injection works for a minimum of 14 ...

The researchers used a unique heparanase inhibitor, OVZ/HS-1638, to therapeutically target the glycocalyx in type 2 diabetic mouse models.

The present study used a widely recognized type 1 diabetes mouse model, the non-obese diabetic or NOD mice, to understand the impaired hypoglycemia-induced secretion of glucagon in type 1 diabetes.

They found that the SCAN enzyme was essential for normal insulin action, but also discovered heightened SCAN activity in diabetic patients and mice with diabetes. Mouse models without the SCAN enzyme ...

In a new Scientific Reports study, curcumin protected bone-forming cells from high-glucose damage by activating the ...

Tested on isolated human and mouse pancreatic islets, mouse and rat cell cultures and animal models of both Type 1 and Type 2 diabetes, the experimental drug significantly improved four detrimental ...

A new hydrogel formulation restores blood flow to diabetic wounds and helps them heal. | Drug Discovery And Development ...

New research from the Charles Perkins Center at the University of Sydney has uncovered a new biological pathway that may help ...